Mosaic ImmunoEngineering Inc.
OTC: CPMV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Steven W. King
- Employees
- 2
- Headquarters
- Huntington Beach, United States
- IPO year
- 2013
- Market cap
- $4.9M
- Website
- https://www.mosaicie.com
Loading CPMV…
Loading profile data…Frequently asked questions about CPMV
What does Mosaic ImmunoEngineering Inc. (CPMV) do?
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-...
Where does CPMV trade?
Mosaic ImmunoEngineering Inc. (CPMV) trades on the Other OTC.
What sector is CPMV in?
Mosaic ImmunoEngineering Inc. (CPMV) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Mosaic ImmunoEngineering Inc.?
Steven W. King is the chief executive officer of Mosaic ImmunoEngineering Inc. (CPMV).
Where is Mosaic ImmunoEngineering Inc. headquartered?
Mosaic ImmunoEngineering Inc. is headquartered in United States.
Does CPMV pay a dividend?
Mosaic ImmunoEngineering Inc. (CPMV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CPMV go public?
Mosaic ImmunoEngineering Inc. (CPMV) completed its initial public offering in 2013.